Professor Basil Sharrack

MD, PhD, FRCP

Neuroscience, School of Medicine and Population Health

Consultant Neurologist

Honorary Professor of Clinical Neurology

b.sharrack@sheffield.ac.uk
+44 114 271 3909
+44 114 271 3909 (NHS Secretary: Carly Barber)
+44 114 2713684 (fax)
91Ö±²¥ Institute for Translational Neuroscience (SITraN)

Full contact details

Professor Basil Sharrack
Neuroscience, School of Medicine and Population Health
91Ö±²¥ Institute for Translational Neuroscience (SITraN)
385a Glossop Road
91Ö±²¥
S10 2HQ
Profile
  • Consultant Neurologist, Department of Neurosciences, Royal Hallamshire Hospital, 91Ö±²¥ (January 1999 – Present time)
  • Specialist Registrar, the National Hospital for Neurology and Neurosurgery, Queen Square, UCL, London (Feb 98 - Dec 98)
  • Specialist Registrar, Department of Neurology, Chelsea & Westminster Hospital, Imperial Collage, London (Sept 97 - Jan 98)
  • Clinical Research Fellow, United Medical and Dental Schools, Guy’s Hospital, King’s College, London (Jun 94 - Aug 97)
  • Clinical Lecturer, Department of Neurology, Aleppo University Hospital, Aleppo University, Aleppo, Syria (Nov 93 - May 94)
  • Career Registrar, Department of Clinical Neurology, Royal Hallamshire Hospital, 91Ö±²¥ (Feb 91 - Oct 93)
Research interests

Principal academic areas of interest

  • Neuro inflammation and degeneration with reference to multiple sclerosis
  • Therapeutic clinical trials in multiple sclerosis
  • Autologous Haematopoietic stem cell transplantation in multiple sclerosis
  • Cognitive rehabilitation in multiples sclerosis
  • Idiopathic intracranial hypertension

Academic Activity

  • Over 90 peer reviewed original articles (5924 citations; H-Index 30).
  • Over £8,000,000 in grants and income from commercial clinical trials.
  • Eight PhDs and one MD have been awarded, five ongoing PhDs projects.
  • Leading UK role in the design and conduct of clinical trials in multiple sclerosis (includes: first gene therapy trial at the 91Ö±²¥ Teaching Hospitals NSH Foundation Trust and the first phase III Autologous Haematopoietic Stem Cell Transplantation treatment in patients with multiple sclerosis).
Grants
  • Multiple Sclerosis Society
  • National Institute of Health Research (NIHR)
  • Biogen
Professional activities and memberships
  • Director of the 91Ö±²¥ MS Research Clinic
  • Chair of the 91Ö±²¥ Research Ethics Committee
  • Member of the EBMT Autoimmune Diseases Working Party

Links

Basil Sharrack NHS email  NHS Secretary: Carly Barber email